Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nasser Altorki

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|December 21, 2024
Corrigendum to: Lobectomy, segmentectomy, or wedge resection for peripheral clinical T1aN0 non-small cell lung cancer: A post hoc analysis of CALGB 140503 (Alliance)" [The Journal of Thoracic and Cardiovascular Surgery Volume 167, Issue 1, January 2024, Pages 338-347.e1]Nasser Altorki, Xiaofei Wang, Bryce Damman, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 20, 2023
Lobectomy, segmentectomy, or wedge resection for peripheral clinical T1aN0 non-small cell lung cancer: A post hoc analysis of CALGB 140503 (Alliance)Nasser Altorki, Xiaofei Wang, Bryce Damman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2024
Secondary Analysis of the Rate of Second Primary Lung Cancer From Cancer and Leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non-Small-Cell Lung CancerThomas E Stinchcombe, Xiaofei Wang, Bryce Damman, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 17, 2013
Balancing curability and unnecessary surgery in the context of computed tomography screening for lung cancerRaja Flores, Thomas Bauer, Ralph Aye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
ECSA/DPPA2 is an embryo-cancer antigen that is coexpressed with cancer-testis antigens in non-small cell lung cancerThomas John, Otavia L Caballero, Suzanne J Svobodová, et al.
Radiology|November 7, 2023
A 20-year Follow-up of the International Early Lung Cancer Action Program (I-ELCAP)Claudia I Henschke, Rowena Yip, Dorith Shaham, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2014
The International Association Study Lung Cancer (IASLC) Strategic Screening Advisory Committee (SSAC) response to the USPSTF recommendationsJohn K Field, Denise R Aberle, Nasser Altorki, et al.
The Annals of Thoracic Surgery|June 19, 2026
STS Expert Consensus Document (2026) on Addressing Definition and Practices of Sublobar Resection in Non-small Cell Lung CancerOnkar V Khullar, Biniam Kidane, Nasser Altorki, et al.
Annals of Epidemiology|April 10, 2003
Lung cancer risk in white and black AmericansSteven D Stellman, Yu Chen, Joshua E Muscat, et al.
Cancer Immunity|December 2, 2006
Physical interaction of two cancer-testis antigens, MAGE-C1 (CT7) and NY-ESO-1 (CT6)Hearn J Cho, Otavia L Caballero, Sacha Gnjatic, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
The Journal of Thoracic and Cardiovascular Surgery|December 21, 2024
Corrigendum to: Lobectomy, segmentectomy, or wedge resection for peripheral clinical T1aN0 non-small cell lung cancer: A post hoc analysis of CALGB 140503 (Alliance)" [The Journal of Thoracic and Cardiovascular Surgery Volume 167, Issue 1, January 2024, Pages 338-347.e1]Nasser Altorki, Xiaofei Wang, Bryce Damman, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 20, 2023
Lobectomy, segmentectomy, or wedge resection for peripheral clinical T1aN0 non-small cell lung cancer: A post hoc analysis of CALGB 140503 (Alliance)Nasser Altorki, Xiaofei Wang, Bryce Damman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2024
Secondary Analysis of the Rate of Second Primary Lung Cancer From Cancer and Leukemia Group B 140503 (Alliance) Trial of Lobar Versus Sublobar Resection for T1aN0 Non-Small-Cell Lung CancerThomas E Stinchcombe, Xiaofei Wang, Bryce Damman, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 17, 2013
Balancing curability and unnecessary surgery in the context of computed tomography screening for lung cancerRaja Flores, Thomas Bauer, Ralph Aye, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
ECSA/DPPA2 is an embryo-cancer antigen that is coexpressed with cancer-testis antigens in non-small cell lung cancerThomas John, Otavia L Caballero, Suzanne J Svobodová, et al.
Radiology|November 7, 2023
A 20-year Follow-up of the International Early Lung Cancer Action Program (I-ELCAP)Claudia I Henschke, Rowena Yip, Dorith Shaham, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2014
The International Association Study Lung Cancer (IASLC) Strategic Screening Advisory Committee (SSAC) response to the USPSTF recommendationsJohn K Field, Denise R Aberle, Nasser Altorki, et al.
The Annals of Thoracic Surgery|June 19, 2026
STS Expert Consensus Document (2026) on Addressing Definition and Practices of Sublobar Resection in Non-small Cell Lung CancerOnkar V Khullar, Biniam Kidane, Nasser Altorki, et al.
Annals of Epidemiology|April 10, 2003
Lung cancer risk in white and black AmericansSteven D Stellman, Yu Chen, Joshua E Muscat, et al.
Cancer Immunity|December 2, 2006
Physical interaction of two cancer-testis antigens, MAGE-C1 (CT7) and NY-ESO-1 (CT6)Hearn J Cho, Otavia L Caballero, Sacha Gnjatic, et al.
Pageof 10